Showing results (211-220 of 630) with videos related to

Sort By:
Pageof 63
American Journal of Therapeutics|October 3, 2009
Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitroVictor L Serebruany, Mohamed El Mouelhi, Hans-Jürgen Pfannkuche, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2008
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologistsDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2014
A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery diseaseMatthew J Price, Leonardo Clavijo, Dominick J Angiolillo, et al.
Journal of Thrombosis and Thrombolysis|September 6, 2024
Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospitalMattia Galli, Sergio Terracina, Eleonora Schiera, et al.
Platelets|April 5, 2018
Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromesStefano Cornara, Gabriele Crimi, Alberto Somaschini, et al.
Platelets|December 6, 2017
Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromesGabriele Crimi, Alberto Somaschini, Marco Cattaneo, et al.
JACC. Basic to Translational Science|January 31, 2020
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 StudyFrancesco Franchi, Fabiana Rollini, Victor Kairouz, et al.
Thrombosis and Haemostasis|October 21, 2011
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivityPiera Capranzano, Claudia Tamburino, Davide Capodanno, et al.
International Journal of Cardiology|March 12, 2026
Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 surveyDominick J Angiolillo, David Erlinge, Chris P Gale, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 7, 2015
Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitusLeonardo C Clavijo, Juan Maya, Glenn Carlson, et al.
Pageof 63